Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Supply Chain
Pharma
New bill sets decoupling deadline for industry's work with WuXi
The amended BIOSECURE Act adds WuXi Biologics to its list of targets and gives companies until the start of 2032 to halt work with the Chinese CDMO giants.
Angus Liu
May 10, 2024 11:30am
BIO survey finds sudden CDMO decoupling could harm patients
May 9, 2024 10:00am
Merck's BCG monopoly could end
May 3, 2024 10:50am
Eli Lilly's Mounjaro, Zepbound supply outlook worsens
Apr 18, 2024 10:22am
US shortage tally reaches all-time high, pharmacist group says
Apr 11, 2024 10:12am
Lilly's Mounjaro will be in short supply through April, FDA says
Apr 2, 2024 5:12pm